Galocitabine

DB21373ExperimentalSmall molecule

Galocitabine is a small molecule drug. The usage of the INN stem '-citabine' in the name indicates that Galocitabine is a nucleoside antiviral or antineoplastic agent, cytarabine or azacitidine derivative.... Galocitabine has a monoisotopic molecular weight of 439.14 Da.

Formula / weight: C₁₉H₂₂FN₃O₈ · 439.396 g/mol (avg)
Code names: RO 09-1390

Resolves to

Compound

UNIIX9788XI79OCAS124012-42-6ChEMBLCHEMBL2106813ChEBI752240PubChem65950

Structure

InChIKeyTVYPSLDUBVTDIS-FUOMVGGVSA-NSMILESCOC1=CC(=CC(OC)=C1OC)C(=O)NC1=NC(=O)N(C=C1F)[C@@H]1O[C@H](C)[C@@H](O)[C@H]1O

Targets

P12461TMP1

What you can answer from here — as of September 23, 2026

1Protein targetEach mapped to UniProt, with action and pharmacological action

Listed above

1+ReferenceStructured and connected to the statements they support

Which drugs share a target with Galocitabine, and which of those have an active Phase 3 trial?

Answer this in Biopharma OS Sign in to your account

Create a free account or log in to explore the full data card.

Create Account